D-0689-2026 Class II Ongoing

Recalled by Chiesi USA, Inc. — Cary, NC

FDA drug recall D-0689-2026 was initiated by Chiesi USA, Inc. on Jul 6, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 44280 vials.

Recall details

Product Type
Drugs
Report Date
Jul 22, 2026
Initiation Date
Jul 6, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
44280 vials

Product description

CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10.

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide within the United States

Code information

Lot #: 1239521, 1237454, Exp. Date 10/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0689-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0689-2026. Report a data issue: hello@regdatalab.com.